SuperworthRockwell Medical price to free cash flow RMTI
Market value divided by free cash flow over the last twelve months, since 2025.
- Today, Oct 23, 2026
- 18.2×
- Peer median
- 11.4×
Rockwell Medical's price to free cash flow is 18.2× as of Oct 23, 2026.
The median for 4 large drugmakers of a similar size is 11.4×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 18.2× | 12.4× | 22.6× |
| 2025 | 12.6× | 12.6× | 21.9× |
Against its peers
Companies in Drug Manufacturers - General nearest Rockwell Medical's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| RMTIRockwell Medical | 18.2× |
| ATNMActinium Pharmaceuticals | n/m |
| SPROSpero Therapeutics | n/m |
| LFVNLifevantage | 11.0× |
| NATRNatures Sunshine Products | 11.8× |
| Peer median | 11.4× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Rockwell Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.